Watch · Quality 22/100
Simple research view
DXCM · DexCom, Inc.
$73.37 latest stored close
Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$DXCM
DexCom, Inc.DexCom, Inc. is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $28B.
Council read · 6 methods
Watch — evidence is building
0 buyable · 5 watch · 1 avoid. Review the observed passes and blockers before reading the chart.
Earnings-risk mode
Pre-earnings setup
Wednesday, July 29, 2026
Time not confirmed
No sourced report session or clock time
Ordinary position sizing suppressed.
Earnings are less than three full trading sessions away; treat the gap as event risk, not ordinary stop-distance risk.
Deterministic evidence
DXCM+2.56%
Sector proxy · XLV+0.51%
Broad market · SPY+0.02%
CatalystUnavailable
Stock reactionPositive
Sector reactionSupportive
Opening surgeUnavailable
Event riskEarnings-driven
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.
AI interpretation (optional)
Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.
Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.DXCM Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Setup Quality
B
4/7 signals
Score trend
✓
Stage 2 · Advancing
✗
Power Trend 1d
✗ RS New High
✓ Trend 7/8
✗
No Pattern
✓ CANSLIM 62.4 (C)
✓ Gatekeeper
Base #3 (C)
Technical Analysis Report Card
$DXCM · $73.37 · as of 2026-07-27 · multi-factor read
67
/ 100
Trend · Daily / Weekly / Monthly
Daily
▲ Uptrend
Weekly
▲ Uptrend
Monthly
▲ Uptrend
Moving Averages
50-day$72.00 ↑
100-day$67.86 ↑
200-day$67.54 ↑
Bullish (50 > 200)
RSI (14)
Reading51.6 · Neutral
Neutral — momentum is balanced between buyers and sellers.
MACD (12/26/9)
StateWeakening
Histogram-0.385
Weakening — MACD slipped below its signal line. Histogram expanding.
Bollinger Bands (20,2)
%B / Width53% · 14.8%
Mid-band — no directional band edge in play.
Volume · Buyer vs Seller
Up/Down vol1.14 · Neutral
Rel volume0.89×
Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.
Support & Resistance
R · $74.92swing level
R · $75.97swing level
R · $79.03swing level
Price · $73.37now
S · $67.30swing level
S · $65.19swing level
S · $63.82swing level
Fibonacci · Uptrend swing
23.6% ◄ price here$73.86
38.2%$70.58
50.0%$67.94
61.8%$65.29
78.6%$61.52
Retracement support zones measured from the recent swing low up to the high.
The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for DXCM — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRS 13 (laggard)
Want this read in a legend's voice?
💬 Ask a Legend about DXCM
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts
6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
Council consensus:
🟡 5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini B
Trend-template read: 9/12 pass; wait for the soft misses to improve.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $73.37, MA150 $68.69, MA200 $67.54
1.2 150-day MA > 200-day MAMA150 $68.69 vs MA200 $67.54
Failing evidence
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 13
2. Quarterly EPS growth ≥ 25%+24.4% QoQ
Avoid
O'Neil D
CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
Passing evidence
A: Annual earnings & revenue qualityRev +15.6% | ROE 33.8%
S: Base tightness (ATR% ≤ 4.5%)ATR% 3.81%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%+24.4% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 13
Watch
Weinstein C
Stage-analysis read: Stage 2 is present; 3 supporting checks need improvement.
Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $73.37 vs MA200 $67.54
Failing evidence
Volume expansion above averageVolume ratio 0.89x
Relative strength ≥ 60RS 13
Watch
Livermore B
Pivotal-point read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$73.37
Distance from 52-week high18.5% below high
Failing evidence
Relative strengthRS 13
Volume vs average0.89x
Watch
Darvas B
Box-theory read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$73.37
Distance from 52-week high18.5% below high
Failing evidence
Relative strengthRS 13
Volume vs average0.89x
Watch
Wyckoff B
Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$73.37
Distance from 52-week high18.5% below high
Failing evidence
Relative strengthRS 13
Volume vs average0.89x
Breakout Health
No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?
RS Line vs SPY
52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
▲ Rising
Accumulation / Distribution
last 65 sessions · green = acc on high vol · red = dist on high vol
Net -2
Fundamentals & leadership quality — Minervini SEPA criteria · 4/7 met
B
4/7 SEPA
Separate score from the 8-point Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
+24%
Revenue growth ≥20% YoY
+16%
Gross margin ≥30%
63%
ROE ≥17%
34%
RS rating ≥80 (leadership)
13
Stage 2 uptrend (Weinstein)
Stage 2
Within 25% of 52W high
-18.5%
Method Playbook
📋 Trade it like Livermore
EXACT LEVELS · PRO
Livermore B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro levelPublished-method rule: Treat the resistance break as a pivotal point only while the primary trend and relative strength remain aligned.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro levelPublished-method rule: Wait for price and volume to confirm the pivotal-point break; anticipation below the line is not confirmation.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro levelPublished-method rule: Place the initial stop below the pivotal line or the reaction low that would prove the breakout false.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-basedPublished-method rule: Raise protection beneath successive higher reaction lows as the trend advances; never move a protective line farther away.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro levelPublished-method rule: Exit when price fails the pivotal line, breaks the latest meaningful reaction low, or shows abnormal reversal action.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
Pattern Analysis
49.1
score
RS Score
13
Trend
7/8 ✓
CANSLIM
62.4* (C)
range low: 59.937
range high: 73.163
range pct: 0.221
sos thrust: 0.066
sos vol ratio: 1.288
sos bars ago: 7
near lps: ✓
validation reason: valid generic setup
multi tf evaluated: ✓
multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
Wyckoff SOS
SOS: breakout above range_high=73.16, thrust=6.6%, vol=1.3x avg, lps=near, 7 bars ago | Strong trend (7/8) | High-confidence pattern (78%) | Stage 2 | Readiness 68/100 (watch) | CANSLIM 62.4 (C) | ⚠ Volatility widening into breakout; 3rd-stage base
The Universal Edge Check
The panel is uneasy
Too many universals unmet — this leans closer to a guess than a trade.
1/7
universals met
- In a confirmed uptrend Stage 2 · Trend 7/8
- Risk is defined No stop — undefined risk
- Asymmetric reward No target set
- Not chasing (in range) Pivot distance unknown
- Volume confirms 0.9× average — light
- Clear of earnings in 1 days — event risk
- A relative-strength leader RS 11 — laggard
Minervini Trend Template
7/8Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
Price above SMA 150 & 200
$73.37 vs SMA150 $68.69 / SMA200 $67.54
SMA 150 above SMA 200
SMA150 $68.69 vs SMA200 $67.54
SMA 200 trending up
Slope +0.27 over 20 days
SMA 50 above SMA 150 & 200
SMA50 $72.00
Price above SMA 50
$73.37 vs SMA50 $72.00
30%+ above 52W low
+35.6% from $54.11
Within 25% of 52W high
-18.5% from $89.98
RS score above 70
RS 13
Fundamentals
52W Range
54%
Mkt Cap SEC
28.3B
EPS QoQ
+24%
Rev YoY
+16%
ROE
34%
Gross Margin
63%
D/E
0.47
EPS TTM
$2.09
P/E TTM
35.1x
Float
386M
Insider
No Buy
Company
Legend AI snapshot
DexCom, Inc.
$73.37latest close
$28.3Bmarket cap
11RS rank
49setup score
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
C
62.4* CANSLIM
* disqualified on C, M
C · Curr. EPS
92
A · Annual EPS
88
N · New Highs
40
S · Supply/Demand
80
L · Leader RS
13
I · Inst. Spons.
100
M · Market
30
Weekly Context
Multi-timeframe signals from weekly barsW. Trend
6/8
W. RS
57
W. Support
$56.72
W. Resist
$79.15
Weekly Structure
Trend
Neutral
Tight Weeks
0
Confirmation
Neutral
Scan History
13× streakJul 28
Wyckoff SOS
✓ Gate
49
Jul 28
Wyckoff SOS
✓ Gate
49
Jul 27
watchlist_candidate
0
0.0%
Jul 23
Trend Only
✓ Gate
49
+4.1%
Jul 22
Trend Only
✓ Gate
61
+2.7%
Get the full picture on DXCM
Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.
Start 7-Day Free Trial